Status:

RECRUITING

Kids With Iron Deficiency and Scoliosis

Lead Sponsor:

Columbia University

Collaborating Sponsors:

National Institute of General Medical Sciences (NIGMS)

Conditions:

Adolescent Idiopathic Scoliosis

Neuromuscular Scoliosis

Eligibility:

All Genders

10-26 years

Phase:

NA

Brief Summary

This study is a randomized controlled trial of preoperative oral iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood c...

Detailed Description

Adolescents undergoing spinal fusion surgery for scoliosis are poised to benefit from preoperative iron supplementation. Spinal fusion carries a risk of large surgical blood losses and perioperative r...

Eligibility Criteria

Inclusion

  • 10-26 years old;
  • diagnosis of scoliosis or kyphosis;
  • self-reported ability to swallow a tablet;
  • spinal fusion procedure planned approximately 6 to 24 weeks from an orthopedic surgical clinic visit at which patient agrees to phlebotomy for screening blood work;
  • serum ferritin less than or equal to 25 µg/L.

Exclusion

  • taking or planning to take iron-containing supplement on patient's own volition, and not willing to stop for duration of study;
  • taking or planning to take iron-containing supplement as prescribed or recommended under the care of a physician;
  • Hg \<10mg/dL if post-menarchal, Hg \< 11 if premenarchal or male
  • C-reactive protein \> 10 mg/L
  • receiving nutritional support by report in the medical chart;
  • self-reported history of hypersensitivity reaction to iron-containing supplements;
  • self-reported history of or suspected non-iron deficient hematologic disorder;
  • self-reported history of iron overloaded state such as hereditary hemochromatosis or hemosiderosis;
  • objection to receiving red blood cell transfusions;
  • current pregnancy (by self-report);
  • prisoners;
  • patient or parent decides against study participation.

Key Trial Info

Start Date :

January 11 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2028

Estimated Enrollment :

275 Patients enrolled

Trial Details

Trial ID

NCT06042699

Start Date

January 11 2024

End Date

February 1 2028

Last Update

July 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Columbia University Medical Center

New York, New York, United States, 10032